The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Labcorp Holdings Inc (NYSE: LH) closed at $272.54 in the last session, up 1.20% from day before closing price of $269.31. In other words, the price has increased by $1.20 from its previous closing price. On the day, 0.53 million shares were traded. LH stock price reached its highest trading level at $272.66 during the session, while it also had its lowest trading level at $268.0199.
Ratios:
We take a closer look at LH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.32 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.69.
On April 02, 2025, Redburn Atlantic started tracking the stock assigning a Buy rating and target price of $276.
Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $250 to $300.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 13 ’25 when van der Vaart Sandra D bought 3,903 shares for $271.42 per share.
Schechter Adam H sold 5,643 shares of LH for $1,505,440 on Aug 11 ’25. The President & CEO now owns 93,319 shares after completing the transaction at $266.78 per share. On Aug 11 ’25, another insider, Schechter Adam H, who serves as the Officer of the company, bought 5,643 shares for $266.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LH now has a Market Capitalization of 22648074240 and an Enterprise Value of 28620773376. As of this moment, Labcorp’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.05, and their Forward P/E ratio for the next fiscal year is 15.49. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.68 while its Price-to-Book (P/B) ratio in mrq is 2.67. Its current Enterprise Value per Revenue stands at 2.123 whereas that against EBITDA is 15.701.
Stock Price History:
The Beta on a monthly basis for LH is 0.85, which has changed by 0.21366227 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, LH has reached a high of $283.47, while it has fallen to a 52-week low of $209.38. The 50-Day Moving Average of the stock is 5.43%, while the 200-Day Moving Average is calculated to be 12.00%.
Shares Statistics:
According to the various share statistics, LH traded on average about 728.69K shares per day over the past 3-months and 548630 shares per day over the past 10 days. A total of 82.90M shares are outstanding, with a floating share count of 82.82M. Insiders hold about 0.33% of the company’s shares, while institutions hold 95.98% stake in the company. Shares short for LH as of 1753920000 were 2748516 with a Short Ratio of 3.77, compared to 1751241600 on 3559484. Therefore, it implies a Short% of Shares Outstanding of 2748516 and a Short% of Float of 4.3.
Dividends & Splits
The forward annual dividend rate for LH is 2.88, which was 2.88 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.010693996The current Payout Ratio is 32.58% for LH, which recently paid a dividend on 2025-05-29 with an ex-dividend date of 2025-08-28. Stock splits for the company last occurred on 2023-07-03 when the company split stock in a 1164:1000 ratio.
Earnings Estimates
The dynamic stock of Labcorp Holdings Inc (LH) is currently being evaluated by a team of 14.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $3.98, with high estimates of $4.04 and low estimates of $3.83.
Analysts are recommending an EPS of between $16.76 and $16.19 for the fiscal current year, implying an average EPS of $16.32. EPS for the following year is $17.63, with 19.0 analysts recommending between $18.21 and $16.95.
Revenue Estimates
According to 12 analysts, the current quarter’s revenue is expected to be $3.56B. It ranges from a high estimate of $3.58B to a low estimate of $3.53B. As of the current estimate, Labcorp Holdings Inc’s year-ago sales were $3.28BFor the next quarter, 12 analysts are estimating revenue of $3.58B. There is a high estimate of $3.62B for the next quarter, whereas the lowest estimate is $3.53B.
A total of 17 analysts have provided revenue estimates for LH’s current fiscal year. The highest revenue estimate was $14.05B, while the lowest revenue estimate was $13.94B, resulting in an average revenue estimate of $14B. In the same quarter a year ago, actual revenue was $13.01BBased on 17 analysts’ estimates, the company’s revenue will be $14.67B in the next fiscal year. The high estimate is $14.87B and the low estimate is $14.51B.
